Interim trial data shows low effectiveness for CureVac shot

Jun 16, 2021, 3:50 PM | Updated: 5:50 pm

BERLIN (AP) — German vaccine maker CureVac said Wednesday that interim data from late-stage testing of its coronavirus shot show a comparatively low effectiveness in protecting people against COVID-19.

The results appear to be a significant setback for CureVac’s efforts to develop a coronavirus vaccine, and the company’s stock value tumbled in after-hours trading.

While not all the data from its trial involving 40,000 participants in Latin America and Europe have been assessed yet, the company said interim results show the vaccine has an efficacy of 47% against COVID-19 disease of any severity.

This did not meet what the company said were its “prespecified statistical success criteria,” though it didn’t state what those were.

The World Health Organization has said vaccines with an efficacy above 50% are worth using, though many of those already approved have a far higher rate.

CureVac said that the study was hampered by the broad range of variants found among the COVID-19 cases reviewed in the trial and that final results may still change.

“While we were hoping for a stronger interim outcome, we recognize that demonstrating high efficacy in this unprecedented broad diversity of variants is challenging,” its chief executive, Franz-Werner Haas, was quoted as saying.

Haas said CureVac would continue to work on a final analysis and “the overall vaccine efficacy may change.”

The company said it has sent the data to the European Medicines Agency, which is conducting a rolling revue of the vaccine.

“The study is continuing to the final analysis and the totality of the data will be assessed for the most appropriate regulatory pathway,” CureVac said.

Outside experts called the data so far disappointing, but cautioned against comparing it directly with other shots already authorized for use.

Deborah Fuller, a professor of microbiology and vaccine specialist at the University of Washington School of Medicine, said CureVac was dealing with “quite a different environment” than some of its rivals who had tested their shots when the original variant was still dominant.

CureVac’s trials took place in 10 different countries, she noted: “The more countries you’re testing in, the more variants you have to test against.”

Another issue could be the mRNA technology used in the CureVac shot, which is slightly different to that employed in the BioNTech-Pfizer and Moderna vaccines, said Mark Slifka, a professor of microbiology and immunology at Oregon Health and Science University.

CureVac uses unmodified mRNA, which may trigger a different immune response in the body that affects the efficacy, he said.

“It could be the variants, it could be the type of mRNA, or it could be a combination of all of the above,” said Slifka.

Haas, the chief executive, said the large number of variants CureVac encountered in its trial — with only a single case of COVID-19 attributable to the original variant — “underlines the importance of developing next-generation vaccines as new virus variants continue to emerge.”

___

Follow all of AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic, https://apnews.com/hub/coronavirus-vaccine and https://apnews.com/UnderstandingtheOutbreak

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

AP

President Joe Biden waves to the media as he walks to board Air Force One at Andrews Air Force Base...
Associated Press

Biden’s mission in Europe: Shore up alliance against Russia

WASHINGTON (AP) — President Joe Biden is out to sustain the global alliance punishing Russia for its invasion of Ukraine as he embarks on a five-day trip to Europe as the four-month-old war shows no sign of abating and its aftershocks to global food and energy supplies are deepening. Biden first joins a meeting of […]
8 hours ago
Associated Press

Pfizer says tweaked COVID-19 shots boost omicron protection

Pfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is safe and works — just days before regulators debate whether to offer Americans updated booster shots this fall. The vaccines currently used in the U.S. still offer strong protection against severe COVID-19 disease and death — especially if people have […]
8 hours ago
President Joe Biden prepares to stand after signing into law S. 2938, the Bipartisan Safer Communit...
Associated Press

Highlights of bipartisan gun violence bill signed by Biden

Highlights of the bipartisan gun violence bill that President Joe Biden signed on Saturday: –Expanded background checks: State and local juvenile and mental health records of gun purchasers will be part of federal background checks for buyers age 18 to 20. Three-day maximum for gathering records will be lengthened to up to 10 days to […]
8 hours ago
Associated Press

Religious schools may steer clear of tuition despite ruling

AUGUSTA, Maine (AP) — Religious schools got what they wanted when the Supreme Court allowed them to participate in a state tuition program. But the state attorney general said the ruling will be for naught unless the schools are willing to abide by the same antidiscrimination law as other private schools that participate in the […]
8 hours ago
President Joe Biden signs into law S. 2938, the Bipartisan Safer Communities Act gun safety bill, i...
Associated Press

Biden signs landmark gun measure, says ‘lives will be saved’

WASHINGTON (AP) — President Joe Biden on Saturday signed the most sweeping gun violence bill in decades, a bipartisan compromise that seemed unimaginable until a recent series of mass shootings, including the massacre of 19 students and two teachers at a Texas elementary school. “Time is of the essence. Lives will be saved,” he said […]
8 hours ago
FILE - This Sept. 20, 2017, file photo shows a sign at the Disney store on the Champs Elysees Avenu...
Associated Press

Abortion ruling thrusts companies into divisive arena

The Supreme Court’s decision to end the nation’s constitutional protections for abortion has catapulted businesses of all types into the most divisive corner of politics. Some companies that stayed silent last month — when a draft opinion by Justice Samuel Alito was leaked to Politico — spoke up for the first time Friday, including The […]
8 hours ago

Sponsored Articles

...

Most plumbing problems can be fixed with regular maintenance

Instead of waiting for a problem to happen, experts suggest getting a head start on your plumbing maintenance.
...
Day & Night Air

Tips to lower your energy bill in the Arizona heat

Does your summer electric bill make you groan? Are you looking for effective ways to reduce your bill?
...
Canvas Annuity

The secret to guaranteed retirement income

Annuities aren’t really a secret, but they are so misunderstood that they might as well be. Once you understand what an annuity is and how it can benefit you, you could decide this “secret” is the perfect supplement to your retirement plan.
Interim trial data shows low effectiveness for CureVac shot